| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 04/21/2011 | US20110093968 Cotton Variety ST 5288B2F |
| 04/21/2011 | US20110093967 Genomically multiplied rapeseed plants, compositions derived therefrom and uses of same |
| 04/21/2011 | US20110093966 Plant height regulatory gene and uses thereof |
| 04/21/2011 | US20110093965 Phospholipases, nucleic acids encoding them and methods for making and using them |
| 04/21/2011 | US20110093964 Uranium-chelating peptides and uses thereof |
| 04/21/2011 | US20110093963 Enhanced Expression of Human or Humanized Immunoglobulin in Non-Human Transgenic Animals |
| 04/21/2011 | US20110093962 Breast disease targets and uses thereof |
| 04/21/2011 | US20110093020 Poly-porous hollow screw for target delivery of growth factors and stem cells:the design and potential clinical application |
| 04/21/2011 | US20110092961 Artificial cells |
| 04/21/2011 | US20110092949 Immunoisolation patch system for cellular transplantation |
| 04/21/2011 | US20110092919 Method and apparatus for harvesting and dispensing a fibrin clot |
| 04/21/2011 | US20110092695 Cell culture model for acquired chemoresistance of chronic myelogenous leukemia and related methods for identifying agents to overcome resistance |
| 04/21/2011 | US20110092573 Modification of myd88 splicing using modified oligonucleotides |
| 04/21/2011 | US20110092572 Modulation of growth hormone receptor expression and insulin-like growth factor expression |
| 04/21/2011 | US20110092571 Compositions and methods for sirna inhibition of icam-1 |
| 04/21/2011 | US20110092569 Administration of Exogenous mi/siRNA |
| 04/21/2011 | US20110092567 Cannabinoid 2 (Cb2) Receptor Gene Promoter and Unique RNA Transcripts in B Cells and Methods of Use |
| 04/21/2011 | US20110092545 Compounds, Compositions and Methods for Stabilizing Transthyretin and Inhibiting Transthyretin Misfolding |
| 04/21/2011 | US20110092530 Cyclopamine tartrate salt and uses thereof |
| 04/21/2011 | US20110092522 Wound and Skin Care Procuts |
| 04/21/2011 | US20110092489 3-Aryl-Substituted Quinazolones, and Uses Thereof |
| 04/21/2011 | US20110092464 Neurogenesis by modulating angiotensin |
| 04/21/2011 | US20110092461 Pyridyl inhibitors of hedgehog signalling |
| 04/21/2011 | US20110092452 Compositions and methods for diagnosing and treating pancreatic cancer |
| 04/21/2011 | US20110092429 Compositions and methods for producing gamma-carboxylated proteins |
| 04/21/2011 | US20110092422 Elastin based growth factor delivery platform for wound healing and regeneration |
| 04/21/2011 | US20110092417 Leptin fusion proteins |
| 04/21/2011 | US20110092411 Recombinant lactoferrins, methods of production from plants and uses thereof |
| 04/21/2011 | US20110092409 Variants of a family 44 xyloglucanase |
| 04/21/2011 | US20110092388 Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancer |
| 04/21/2011 | US20110092378 Isolation and use of solid tumor stem cells |
| 04/21/2011 | US20110091976 Regulatory region preferentially expressing to seed embryo and method of using same |
| 04/21/2011 | US20110091975 Down-regulation of gene expression using artificial micrornas |
| 04/21/2011 | US20110091974 Conductive Substrate and Method for Introducing Nucleic Acid |
| 04/21/2011 | US20110091973 Modified and fusion enhanced erythrocytes, cells and uses thereof |
| 04/21/2011 | US20110091972 Fabricating Scaffolds and Other Cell-Growth Structures Using Microfluidics to Culture Biological Samples |
| 04/21/2011 | US20110091971 Differentiation of Pluripotent Stem Cells |
| 04/21/2011 | US20110091970 Methylation of estrogen receptor alpha and uses thereof |
| 04/21/2011 | US20110091969 Mutations in the ns5b protein of the hcv |
| 04/21/2011 | US20110091968 Monoclonal antibody specific to both human interferon-alpha subtype alpha 8 and its mutant proteins |
| 04/21/2011 | US20110091967 Ssx-4 peptides presented by hla class ii molecules |
| 04/21/2011 | US20110091959 Multiply-Substituted Protease Variants |
| 04/21/2011 | US20110091958 Multiply-Substituted Protease Variants |
| 04/21/2011 | US20110091936 Production of proteins in glutamine-free cell culture media |
| 04/21/2011 | US20110091934 Laccase Variants |
| 04/21/2011 | US20110091930 Well-based flow system for cell culture |
| 04/21/2011 | US20110091928 Agent for Recruitment of Bone-Marrow-Derived Pluripotent Stem Cell Into Peripheral Circulation |
| 04/21/2011 | US20110091927 Motor neurons developed from stem cells |
| 04/21/2011 | US20110091926 Perfusable bioreactor for the production of human or animal tissues |
| 04/21/2011 | US20110091920 METHOD OF DIAGNOSING A CLINICAL CONDITION BY DETECTION OF A PAPP-A/proMBP COMPLEX |
| 04/21/2011 | US20110091901 Vectors and Methods for Screening Cells for High Expression of Protein of Interest (POI) |
| 04/21/2011 | US20110091892 Methods for the Diagnosis and Treatment of Lung Cancer |
| 04/21/2011 | US20110091890 Trichoplusia ni cell line and methods of use |
| 04/21/2011 | US20110091876 Zcytor19 polynucleotides, polypeptides, antibodies and methods of use |
| 04/21/2011 | US20110091875 Three-component gene expression reporting system for mammalian cells and applications of the same |
| 04/21/2011 | US20110091869 Method for culture of stem cell |
| 04/21/2011 | US20110091862 Generation of an hla-negative osteogenic precursor cell line |
| 04/21/2011 | US20110091574 Treatment of adenocarcinoma expressing lkb1 with mtor inhibitor in combination with cox2 inhibitor |
| 04/21/2011 | US20110091567 Tissue organizing structure and therapeutic methods |
| 04/21/2011 | US20110091562 Nanogels for cellular delivery of therapeutics |
| 04/21/2011 | US20110091561 Perfluorcarbon nanoemulsions with endocytosis enhancing surface for gene-transfer |
| 04/21/2011 | US20110091510 Nanorod materials and methods of making and using same |
| 04/21/2011 | US20110091502 Human parvovirus: humink parvovirus |
| 04/21/2011 | US20110091498 Methods of stimulating an immune response against prostate specific antigen |
| 04/21/2011 | US20110091494 Peptides protective against s. pneumoniae and compositions, methods and uses relating thereto |
| 04/21/2011 | US20110091491 Hiv-1 gp41 neutralization domain and use thereof |
| 04/21/2011 | US20110091485 Modulation of cell junctions |
| 04/21/2011 | US20110091483 Canine Anti-CD20 Antibodies |
| 04/21/2011 | US20110091480 Antigen-Binding Proteins Targeting S. Aureus Orf0657n |
| 04/21/2011 | US20110091479 Novel anti-igf-ir antibodies and uses thereof |
| 04/21/2011 | US20110091477 Modulators of hepatocyte growth factor activator |
| 04/21/2011 | US20110091476 Human Anti-NGF Neutralizing Antibodies as Selective NGF Pathway Inhibitors |
| 04/21/2011 | US20110091469 Attractin/mahogany-like polypeptides, polynucleotides, antibodies and methods of use thereof |
| 04/21/2011 | US20110091465 Polypeptides |
| 04/21/2011 | US20110091464 Novel peptides and protein and uses thereof |
| 04/21/2011 | US20110091463 Dual Variable Domain Immunoglobulins and Uses Thereof |
| 04/21/2011 | US20110091460 Receptor-targeting reagents |
| 04/21/2011 | US20110091452 4,5-Dihydromacbecin Derivatives and Their Use in the Treatment of Cancer or B-Cell Malignancies |
| 04/21/2011 | US20110091441 Meganuclease variants cleaving a dna target sequence from the human interleukin-2 receptor gamma chain gene and uses thereof |
| 04/21/2011 | US20110091439 Cosmetic use of acid ceramidase type proteins |
| 04/21/2011 | US20110091434 Augmentation of cell therapy efficacy including treatment with alpha 1-3 fucosyltransferase |
| 04/21/2011 | US20110091433 Treatment using reprogrammed mature adult cells |
| 04/21/2011 | US20110091430 Mesenchymal stem cells and methods of use thereof |
| 04/21/2011 | US20110091429 Methods for Enhancing Stem Cell Engraftment During Transplantation |
| 04/21/2011 | US20110091428 Compositions of adult organ stem cells and uses thereof |
| 04/21/2011 | US20110091426 Human brain endothelial cells and growth medium and method for expansion of primitive CD34+CD38- bone marrow stem cells |
| 04/21/2011 | US20110091417 Interleukin-22 Polypeptides, Nucleic Acids Encoding The Same And Methods For The Treatment Of Pancreatic Disorders |
| 04/21/2011 | US20110091412 Mutant interleukin-2 (il-2) polypeptides |
| 04/21/2011 | US20110091386 Humanized antibodies specific for amino acid sequence rgd of an extracellular matrix protein and the uses thereof |
| 04/21/2011 | US20110091375 Use of the combination comprising temozolomide and tnf-alpha for treating glioblastoma |
| 04/21/2011 | US20110091372 Dual Variable Domain Immunoglobulins and Uses Thereof |
| 04/21/2011 | US20110088361 Novel tomato plants |
| 04/21/2011 | CA2777720A1 Induction of pluripotent cells |
| 04/21/2011 | CA2777718A1 Closed system separation of adherent bone marrow stem cells for regenerative medicine applications |
| 04/21/2011 | CA2777663A1 Method for treating chronic nerve tissue injury using a cell therapy strategy |
| 04/20/2011 | EP2312482A1 Systems and methods for providing a stem cell bank |
| 04/20/2011 | EP2311973A1 Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof |
| 04/20/2011 | EP2311967A2 Improved AAV vectors produced in insect cells |
| 04/20/2011 | EP2311966A2 Improved AAV vectors produced in insect cells |
| 04/20/2011 | EP2311962A1 Multigenic vectors plasmids and methods for increasing expression of recombinant polypeptides |